2-环己基吡咯烷 | 367281-02-5

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吡咯烷类
• 中文名称: 2-环己基吡咯烷
• 中文别名: 2-环己吡嗪
• 英文名称: 2-cyclohexylpyrrolidine
• 英文别名: 2-cyclohexyl-pyrrolidine；2-Cyclohexyl-pyrrolidin
• CAS: 367281-02-5
• 化学式: C₁₀H₁₉N
• 分子量: 153.268
• InChiKey: KRDXTHSSNCTAGY-UHFFFAOYSA-N

物化性质

• 熔点：
  0°C
• 沸点：
  0°C
• 闪点：
  0°C

计算性质

• 辛醇/水分配系数(LogP)：
  2.7
• 重原子数：
  11
• 可旋转键数：
  1
• 环数：
  2.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  12
• 氢给体数：
  1
• 氢受体数：
  1

安全信息

• 危险品标志：
  Xi
• 安全说明：
  S16,S26,S36/37/39,S9
• 危险类别码：
  R11
• 海关编码：
  2933990090
• 危险品运输编号：
  UN 2733

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
Product Name: 2-Cyclohexylpyrrolidine
Synonyms:

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

---

Section 3. Composition/information on ingredients.
Ingredient name: 2-Cyclohexylpyrrolidine
CAS number: 367281-02-5

---

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels, refrigerated.
Storage:

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C10H19N
Molecular weight: 153.3

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
Non-harzardous for air and ground transportation.

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  2-环己基吡咯烷 在 硼烷铵络合物 、 6-hydroxy-D-nicotine oxidase E₃₅₀L/E₃₅₂D mutant 作用下， 反应 48.0h， 以71%的产率得到(S)-2-Cyclohexylpyrrolidine
  参考文献：
  名称：

  具有宽底物特异性和高对映选择性的R选择性胺氧化酶的开发

  摘要：

  胺氧化酶是用于合成对映体纯的1°，2°和3°手性胺的有用生物催化剂。先前报道的此类酶（例如，来自黑曲霉的MAO-N ）已显示出高度的S选择性。在此，我们报道了基于6-羟基-D-烟碱氧化酶（6-HDNO）的对映体互补R-选择性胺氧化酶的开发，该酶具有扩大的底物范围和高对映选择性。工程化的6-HDNO酶已应用于一系列外消旋胺的制备脱硝反应，以产生具有S构型的产物，例如高ee的（S）-烟碱。

  DOI：

  10.1002/cctc.201301008
• 作为产物：
  描述：

  2-苯基吡咯烷 在 platinum(IV) oxide 、 氢气 、 溶剂黄146 作用下， 以 四氢呋喃 、 甲醇 为溶剂， 65.0 ℃ 、344.75 kPa 条件下， 反应 12.0h， 生成 2-环己基吡咯烷
  参考文献：
  名称：

  WO2019210828A5

  摘要：

  公开号：

  WO2019210828A5

文献信息

• [EN] ASH1L INHIBITORS AND METHODS OF TREATMENT THEREWITH<br/>[FR] INHIBITEURS DE ASH1L ET MÉTHODES DE TRAITEMENT AU MOYEN DE CEUX-CI
  申请人：UNIV MICHIGAN REGENTS

  公开号：WO2017197240A1

  公开（公告）日：2017-11-16

  Provided herein are small molecule inhibitors of ASH1L activity and small molecules that facilitate ASH1L degradation and methods of use thereof for the treatment of disease, including acute leukemia, solid cancers and other diseases dependent on activity of ASH1L.

  本文提供了ASH1L活性的小分子抑制剂，促进ASH1L降解的小分子以及它们的使用方法，用于治疗疾病，包括急性白血病、实体肿瘤和其他依赖于ASH1L活性的疾病。
• Synthetic cascades are enabled by combining biocatalysts with artificial metalloenzymes
  作者：V. Köhler、Y. M. Wilson、M. Dürrenberger、D. Ghislieri、E. Churakova、T. Quinto、L. Knörr、D. Häussinger、F. Hollmann、N. J. Turner、T. R. Ward

  DOI：10.1038/nchem.1498

  日期：2013.2

  within a host protein affords an artificial transfer hydrogenase (ATHase) that is fully compatible with and complementary to natural enzymes, thus enabling efficient concurrent tandem catalysis. To illustrate the generality of the approach, the ATHase was combined with various NADH-, FAD- and haem-dependent enzymes, resulting in orthogonal redox cascades. Up to three enzymes were integrated in the cascade

  酶催化和均相催化提供互补的方法来应对化学和生物学中的合成挑战。尽管具有吸引力，但由于两种催化剂的相互失活，将有机金属催化剂与酶结合的并发级联反应的实施已被证明具有挑战性。为了解决这个问题，我们表明结合 a d 6宿主蛋白质中的钢琴粪便复合物提供了一种与天然酶完全兼容和互补的人工转移氢化酶 (ATHase)，从而实现高效的并发串联催化。为了说明该方法的通用性，将 ATHase 与各种 NADH、FAD 和血红素依赖性酶结合，产生正交氧化还原级联反应。多达三种酶被整合到级联中并与 ATHase 结合，以实现 (i) 双立体选择性胺去消旋，(ii) 辣根过氧化物酶偶联的转移氢化酶活性读数，以实现其遗传优化，(iii)从L形成L-哌啶酸-赖氨酸和 (iv) NADH 的再生以促进单加氧酶催化的氧化功能化反应。
• Catalyst-Controlled Diastereoselective Synthesis of Cyclic Amines via C-H Functionalization
  作者：Sailu Munnuri、Adeniyi Michael Adebesin、Mahesh P Paudyal、Muhammed Yousufuddin、Alfonso Dalipe、John R. Falck

  DOI：10.1021/jacs.7b09901

  日期：——

  restrictions, especially in complex molecule synthesis. This report describes a catalyst-controlled regio- and diastereoselective synthesis of N-unprotected pyrrolidines via dirhodium catalyzed intramolecular nitrene insertion into sp3 C-H bonds. The reaction proceeds at rt without external oxidants, nitrene stabilizing groups, or directing functionality. The insights that emerged from the conforma

  由于区分多个相对强的 sp3 CH 键的挑战，这些键的化学行为通常只有细微的差别，因此适用于非活化脂肪族系统的可靠区域和立体化学技术在很大程度上仍然难以捉摸。然而，使用导向基团和/或助剂的方法已经出现，但施加了实际限制，特别是在复杂分子合成中。本报告描述了一种催化剂控制的区域选择性和非对映选择性合成 N-未保护的吡咯烷，通过 dirhodium 催化分子内氮烯插入 sp3 CH 键。反应在室温下进行，无需外部氧化剂、氮烯稳定基团或导向官能团。
• Aminoacetamide acyl guanidines as beta-secretase inhibitors
  申请人：Gerritz Samuel

  公开号：US20060287287A1

  公开（公告）日：2006-12-21

  There is provided a series of substituted acyl guanidines of Formula (Ik) or a stereoisomer; or a pharmaceutically acceptable salt thereof, wherein R 2 , R 3 , R 4 , R 5 , R 25 , R 26 and R 27 as defined herein, their pharmaceutical compositions and methods of use. These compounds inhibit the processing of amyloid precursor protein (APP) by β-secretase and, more specifically, inhibit the production of Aβ-peptide. The present disclosure is directed to compounds useful in the treatment of neurological disorders related to β-amyloid production, such as Alzheimer's disease and other conditions affected by anti-amyloid activity.

  提供了一系列的取代酰基胍类化合物，符合以下化学式（Ik）或其立体异构体；或其药学上可接受的盐，其中R2、R3、R4、R5、R25、R26和R27如本文所定义，它们的药物组合物和使用方法。这些化合物抑制β-分泌酶对淀粉样前体蛋白（APP）的加工，更具体地说，抑制Aβ肽的产生。本公开涉及对β-淀粉样蛋白产生相关的神经疾病的治疗有用的化合物，如阿尔茨海默氏病和其他受抗淀粉样活性影响的病症。
• DIRECT C-H AMINATION AND AZA-ANNULATION
  申请人：The Board of Regents of the University of Texas System

  公开号：US20190152892A1

  公开（公告）日：2019-05-23

  In some aspects, the present disclosure provides methods of aminating an aromatic compound comprising reacting an aminating agent with an aromatic compound in the presence of a rhodium catalyst. In some embodiments, the methods may comprise aminating an aromatic compound which contains multiple different functional groups. The methods described herein may also be used to create bicyclic system comprising reacting an intramolecular aminating agent with an aromatic ring to obtain a second ring containing a nitrogen atom. In another aspect, the methods described herein may also be used to create a cyclic aliphatic cyclic/poly cyclic amine system comprising a reacting an intramolecular aminating agent by insertion into a C(sp3)-H bond.

  在某些方面，本公开提供了一种芳香化合物胺化的方法，包括在铑催化剂存在下，将胺化剂与芳香化合物反应。在某些实施例中，这些方法可能包括胺化含有多种不同功能基团的芳香化合物。本文描述的方法还可用于创建包含在芳香环中通过反应分子内胺化剂获得含氮原子的第二环的双环系统。在另一方面，本文描述的方法还可用于创建通过插入C(sp3)-H键反应分子内胺化剂的环脂环/多环胺系统。